Cytokeratin 18 Polyclonal Antibody

KRT18 encodes the type I intermediate filament chain keratin 18. Keratin 18, together with its filament partner keratin 8, are perhaps the most commonly found members of the intermediate filament gene family. They are expressed in single layer epithelial tissues of the body. Mutations in this gene have been linked to cryptogenic cirrhosis. Two transcript variants encoding the same protein have been found for KRT18.

Introducing the Cytokeratin 18 Polyclonal Antibody, a cutting-edge scientific tool meticulously designed to revolutionize research in the field of cytokeratin biology. This antibody, crafted with utmost precision and expertise, offers unparalleled specificity and sensitivity, enabling researchers to delve deeper into the intricate mechanisms of cytokeratin 18.

The Cytokeratin 18 Polyclonal Antibody boasts a superior affinity for cytokeratin 18, a key intermediate filament protein found in epithelial cells. Its exceptional binding capacity ensures accurate and reliable detection, facilitating comprehensive analysis of cytokeratin 18 expression patterns and distribution within various tissues and cell types.

With its robust performance, this antibody serves as an invaluable asset in a multitude of applications, including immunohistochemistry, immunofluorescence, and Western blotting. Its versatility allows for seamless integration into diverse experimental protocols, empowering researchers to explore the role of cytokeratin 18 in disease progression, tissue regeneration, and cellular differentiation.

Crafted with the utmost commitment to quality, the Cytokeratin 18 Polyclonal Antibody undergoes rigorous validation processes to ensure consistent and reproducible results. Its exceptional specificity minimizes cross-reactivity, guaranteeing precise and accurate data interpretation. Furthermore, this antibody exhibits exceptional stability, enabling long-term storage without compromising its performance.

In summary, the Cytokeratin 18 Polyclonal Antibody represents a breakthrough in cytokeratin research, offering researchers an unparalleled tool to unravel the complexities of cytokeratin 18 biology. With its exceptional specificity, sensitivity, and versatility, this antibody is poised to drive scientific advancements and pave the way for groundbreaking discoveries in the field.